outcomes-based agreements between Medicaid programs and manufacturers of gene therapies for sickle cell disease. 1 Section of General Internal Medicine, Department of Internal Medicine ...
Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.